
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 882 | 882 | 1015 | 1207 | 2146 | 3691 |
Fund Return | -11.8% | -11.8% | 1.52% | 6.47% | 16.5% | 13.95% |
Place in category | 609 | 609 | 306 | 373 | 110 | 91 |
% in Category | 68 | 68 | 39 | 52 | 23 | 25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 964.2M | -4.99 | 7.63 | 17.40 | ||
AXA Framlington Global Technology F | 964.2M | -4.99 | 7.63 | 17.40 | ||
AXA Framlington Health Fund Z GBP A | 475.74M | -4.22 | 1.08 | 6.44 | ||
AXA Global Distribution R Acc | 237M | 5.74 | -1.26 | 4.97 | ||
AXA Global Distribution R Inc | 237M | 7.05 | -0.84 | 5.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPUS Growth Fund C dist GBP | 5.56B | -13.57 | 10.56 | 17.19 | ||
Baillie Gifford American Fund A Acc | 2.45B | 9.84 | 10.47 | 17.35 | ||
Baillie Gifford American Fund B Acc | 2.45B | 30.92 | -3.08 | 17.58 | ||
Baillie Gifford American Fund B Inc | 2.45B | 9.95 | 11.58 | 18.50 | ||
Edgewood L Select US Select Growthd | 2.94B | 3.44 | 7.59 | 16.18 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 6.74 | 198.15 | +4.06% | |
NVIDIA | US67066G1040 | 6.18 | 110.93 | +3.12% | |
Microsoft | US5949181045 | 5.91 | 388.45 | +1.86% | |
Alphabet C | US02079K1079 | 5.24 | 159.40 | +2.59% | |
Amazon.com | US0231351067 | 4.84 | 184.87 | +2.01% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review